Br J Pharmacol 59(2): 223-229
Mechanism of neurotoxicity of cardiotonic glycosides.
Abstract
1 In cats intracerebroventricular administration of 5, 10, 20 mug of peruvoside, a cardiac glycoside obtained from the plant, Thevetia neriifolia, and 10 and 20 mug of ouabain, produced marked neurotoxicity. This was dose-related. 2 Prior administration reserpine (2 mg/kg i.m., 500 mug i.c.v.) or tetrabenazine (25 mg/kg i.v., 50 mg/kg i.v. and 2 mg/,g i.c.v.) suppressed the neurotoxicity, but lithium carbonate (100 mg/,g i.p., 2 mg 2.c.v.) and haloperidol (200 mug i.c.v.) were ineffective. 3 Prior administration of 2-bromolysergic acid diethylamide (BOL-148, 200 mug i.c.v.) or p-chlorophenylalanine (PCPA) (400 mg/kg i.p.) suppressed the neurotoxicity induced by peruvoside and ouabain. 4 Perfusion of the lateral ventricles of cats with 10, 20 and 30 mug of peruvoside or ouqbain produced a massive release of 5-hydroxytryptamine (5-HT). This was dose-related. Prior administration PCPA suppressed the release of 5-HT. 5 The results of the findings indicate the involvement of 5-HT in the genesis of neurotoxicity induced by peruvoside or ouabain.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (792K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BHATTACHARYA BK, FELDBERG W. Perfusion of cerebral ventricles: effects of drugs on outflow from the cisterna and the aqueduct. Br J Pharmacol Chemother. 1958 Jun;13(2):156–162.[PMC free article] [PubMed] [Google Scholar]
- Buterbaugh GG, Spratt JL. The possible role of brain monoamines in the acute toxicity of digitoxigenin. J Pharmacol Exp Ther. 1970 Oct;175(1):121–130. [PubMed] [Google Scholar]
- FELDBERG W, SHERWOOD SL. Injections of drugs into the lateral ventricle of the cat. J Physiol. 1954 Jan;123(1):148–167.[PMC free article] [PubMed] [Google Scholar]
- Fuxe K, Sjöqvist F. Hypothermic effect of apomorphine in the mouse. J Pharm Pharmacol. 1972 Sep;24(9):702–705. [PubMed] [Google Scholar]
- Gaitonde BB, Joglekar SN. Mechanism of peruvoside-induced emesis. Neuropharmacology. 1972 May;11(3):427–433. [PubMed] [Google Scholar]
- Gaitondé BB, Joglekar SN. Role of catecholamines in the central mechanism of emetic response induced by peruvoside and ouabain in cats. Br J Pharmacol. 1975 Jun;54(2):157–162.[PMC free article] [PubMed] [Google Scholar]
- GAITONDE BB, MCCARTHY LE, BORISON HL. CENTRAL EMETIC ACTION AND TOXIC EFFECTS OF DIGITALIS IN CATS. J Pharmacol Exp Ther. 1965 Mar;147:409–415. [PubMed] [Google Scholar]
- GERSHON S, YUWILER A. Lithium ion: a specific psychopharmacological approach to the treatment of mania. J Neuropsychiatr. 1960 May-Jun;1:229–241. [PubMed] [Google Scholar]
- HOLZBAUER M, VOGT M. Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. J Neurochem. 1956 May;1(1):8–11. [PubMed] [Google Scholar]
- MELVILLE KI, SHISTER HE. General systemic effects and electrocardiographic changes following injections of digitalis glycosides into the lateral ventricle of the brain. Am Heart J. 1957 Mar;53(3):425–438. [PubMed] [Google Scholar]
- MUSCHOLL E, VOGT M. The action of reserpine on the peripheral sympathetic system. J Physiol. 1958 Apr 3;141(1):132–155.[PMC free article] [PubMed] [Google Scholar]
- PLETSCHER A, SHORE PA, BRODIE BB. Serotonin release as a possible mechanism of reserpine action. Science. 1955 Aug 26;122(3165):374–375. [PubMed] [Google Scholar]
- SCHOU M. Lithium in psychiatric therapy. Stock-taking after ten years. Psychopharmacologia. 1959;1:65–78. [PubMed] [Google Scholar]
- SHORE PA, SILVER SL, BRODIE BB. Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system. Experientia. 1955 Jul 15;11(7):272–273. [PubMed] [Google Scholar]
- VANE JR. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349.[PMC free article] [PubMed] [Google Scholar]
- VOGT M. The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J Physiol. 1954 Mar 29;123(3):451–481.[PMC free article] [PubMed] [Google Scholar]
- Vogt M. Functional aspects of the role of catecholamines in the central nervous system. Br Med Bull. 1973 May;29(2):168–172. [PubMed] [Google Scholar]